We often hear about 3D printed scaffolds, which provide structure to printed cells while they grow and develop, being used in the medical field, as they can help with tissue regrowth, have an effect on how cells express signaling proteins that help cancer grow, and improve regeneration. A collaborative team of researchers from the National Taiwan University Hospital, the China Medical University Hospital, and Asia University have been studying 3D printed bone scaffolds lately.
There’s a major need around the world for bone repairs, as the population continues to age and suffer from bone defects and disorders. But one of the worst is destroyed bone in the orofacial region, which could lead to loss of function and a reduced quality of life without surgical intervention to reconstruct the hard tissues using grafts and implants. Many different types of material, like calcium phosphate and calcium sulfate, are used in synthetic bone grafts, but have issues such as a lack of osteoconductivity and manipulation difficulties.
The multi-university research team recently published a paper, titled “Effects of bone morphogenic protein-2 loaded on the 3D-printed MesoCS scaffolds,” that takes a look at the effects of various loading methods on novel grafting material bone morphogenetic protein-2 (BMP-2), which was loaded with a mesoporous calcium silicate (MesoCS) scaffold created with FDM 3D printing on a 3D bioprinter from GeSiM. The team created new bone substitutes that have both osteoconductive and osteoinductive potential.
The team wrote in the paper, “In this study, there are two methods of loading BMP-2: (1) the pre-loading (PL) method by mixing MesoCS and BMP-2 as a raw material for a 3D-printer, and (2) the direct-loading (DL) method by soaking the 3D-printed MesoCS scaffold in a BMP-2 solution. The characteristics of MesoCS scaffold were examined by transmission electron microscopy (TEM), X-ray diffraction (XRD) and scanning electron microscopy (SEM). Their physical properties, biocompatibility, and osteogenic-related ability were also evaluated.”
3D printed scaffolds provide an environment quite similar to in vivo conditions for cell infiltration, and can be made with various biomaterials that help repair bone defects. Materials based in CS have excellent potential for regenerating bone when used as bioactive, biodegradable grafting materials. However, traditional CS powder is limited in drug delivery applications by its limited nanopore structure and large particle sizes, so the researchers developed a mesoporous CS nanoparticle with a diameter between 2 and 50 nm.
“The 3D MesoCS/PCL scaffolds showed excellent biocompatibility and physical properties. After soaking in simulated body fluid, the bone-like apatite layer of the PL and DL groups could be formed. In addition, the DL group released fifty percent more than the PL group at the end of the first day and PL showed a sustained release profile after 2 weeks,” the researchers wrote in the paper.
“The 3D MesoCS/PCL porous scaffolds were successfully fabricated via a 3D printing system and were tested in vitro and were found to show good cellular activity for cell behavior although the PL method was not favorable for clinical application in relation with the preservation of BMP-2. With regards to different growth factor loading methods, this study demonstrated that PL of BMP-2 into MesoCS prior to printing will result in a more sustained drug release pattern as compared to traditional methods of scaffolds directly immersed with BMP-2.”
The study shows that by pre-loading BMP-2 into MesoCS before 3D printing, with regards to differing methods of loading growth factors, there will be a more sustained drug release pattern than traditionally manufactured scaffolds immersed directly with BMP-2.
Co-authors of the paper are Kuo-Hao Huang, Yen-Hong Lin, Ming-You Shie, and Chun-Pin Lin.
Discuss this story and other 3D printing topics at 3DPrintBoard.com or share your thoughts in the Facebook comments below.
You May Also Like
Launcher’s New Orbital Transfer Vehicle to Rideshare on SpaceX Falcon 9 in 2022
Launcher’s new orbit transfer vehicle (OTV) will debut on a SpaceX Falcon 9 rideshare for its inaugural flight to Sun-synchronous orbit (SSO) in October 2022. Known as Launcher Orbiter, the...
SpaceX Successes Drive off-Earth Innovation, So Do Its Failures
After a highly anticipated test launch, SpaceX‘s Starship SN11 prototype finally lifted off for a planned test flight. Climbing up from out of the cloud deck at the company’s South...
From Magnets to Harpoons: How to Catch Space Debris
The world’s first commercial test mission to locate and remove space debris has finally launched to space. On March 22, 2021, Astroscale’s End-of-Life Services demonstration (ELSA-d) mission took off from...
Relativity Space Preparing for Next Year’s Rocket Launch with New VP and Verified 3D Printing Tech
In the last few years, there has been excitement for the new race to the moon. But as deadlines for rocket launches and crewed missions get closer, space companies begin...
View our broad assortment of in house and third party products.